Our paper commented on a large retrospective observational study by Myung and colleagues investigating postcontrast acute kidney injury in patients with stroke undergoing CTA followed by cerebral angiography.1 In this study, the authors found that 9.5% (57 out of 601 patients) of included patients developed postcontrast acute kidney injury. From the patients affected by postcontrast acute kidney injury, only 8.7% (5 out of 57 patients) required some form of renal replacement therapy (which was 0.8% of all patients included in the study). In these 5 patients, kidney function recovered within less than 1 week. The same was holding true for the other patients developing postcontrast acute kidney injury, demonstrating renal function recovery within a short time period.
The importance of this paper lies not only in the excellent examination of postcontrast acute kidney injury, but more importantly in the association of the disease with the requirement for renal replacement therapy and the likelihood of recovery as a crucial clinical outcome parameter.
The study essentially suggests that CTA followed by angiography (in this case in the stroke population) can be pursued safely and that postcontrast acute kidney injury seems to have minor clinical consequences. In other words, the benefits of treating the acute disease far outweigh the risks associated with postcontrast acute kidney injury.